Health Care & Life Sciences » Pharmaceuticals | CSPC Pharmaceutical Group Ltd.

CSPC Pharmaceutical Group Ltd. | Ownership

Companies that own CSPC Pharmaceutical Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
First State Investments (Hong Kong) Ltd.
148,054,000
2.37%
-6,040,000
3.45%
01/31/2018
The Vanguard Group, Inc.
147,274,253
2.36%
-36,000
0.01%
07/31/2018
BlackRock Fund Advisors
102,228,000
1.64%
-22,388,000
0.01%
06/04/2018
Norges Bank Investment Management
93,085,989
1.49%
-10,224,304
0.03%
12/31/2017
Fidelity Management & Research Co.
59,481,394
0.95%
-8,161,262
0.02%
07/31/2018
Investec Asset Management Ltd.
51,313,777
0.82%
-7,268,255
0.28%
07/31/2018
T. Rowe Price International Ltd.
47,496,000
0.76%
-12,072,000
0.22%
06/30/2018
Hang Seng Investment Management Ltd.
33,806,941
0.54%
33,209,389
0.74%
06/29/2018
BlackRock Japan Co., Ltd.
31,486,149
0.5%
13,506,122
0.1%
06/04/2018
Harding Loevner LP
30,576,000
0.49%
2,626,000
0.19%
06/30/2018

About CSPC Pharmaceutical Group

View Profile
Address
Suite 3206, 32nd Floor
Hong Kong
Hong Kong
Employees -
Website http://www.cspc.com.hk
Updated 07/08/2019
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.